Creation would no longer be only production. It would become a way of knowing. Another mind would be a mirror capable of ...

Oracle has released version 27 of the Java programming language and virtual machine. As the second non-LTS release since JDK 25, the final feature set includes nine JEPs, five of which are still ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has been a scorcher for much of the Northern Hemisphere. June and July marked ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals insiders reported 4 transactions totaling $509,752.94. Activity included 2 stock sales and 2 tax-related share dispositions between August and September 2026. View more Major ...